CAS RN: 120447-62-3
(+/-)-VESAMICOL HYDROCHLORIDE
Product Availability
Choose a grade to view its available package options.
8 package records6 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250629 |
25mg / 100mg |
Out of stock |
| 30 business days | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20260326 |
100mg |
In stock |
Shanghai, Shenzhen | | Inquiry |
| Batchno.20260410 |
10mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250130 |
1mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250611 |
250mg |
Out of stock |
| | Inquiry |
| Batchno.20260511 |
25mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250331 |
50mg |
In stock |
Shanghai, Shenzhen | | Inquiry |
| Batchno.20250414 |
5mg |
In stock |
Shanghai | | Inquiry |
-
Product code:
starshine_CAS120447-62-3
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
120447-62-3 / 2-(4-phenylpiperidin-1-yl)cyclohexan-1-ol;hydrochloride
VESAMICOL HYDROCHLORIDE | RefChem:194147 | (+/-)-Vesamicol HCl (AH-5183)
Standard CAS: 120447-62-3
Multi CAS: Yes
Basic Information
CAS
120447-62-3
Multi CAS
Yes
Molecular Formula
C17H26ClNO
Molecular Weight
295.800000
Exact Mass
295.170292
SMILES
C1CCC(C(C1)N2CCC(CC2)C3=CC=CC=C3)O.Cl
InChI
InChI=1S/C17H25NO.ClH/c19-17-9-5-4-8-16(17)18-12-10-15(11-13-18)14-6-2-1-3-7-14;/h1-3,6-7,15-17,19H,4-5,8-13H2;1H
InChIKey
XJNUHVMJVWOYCW-UHFFFAOYSA-N
Synonyms
VESAMICOL HYDROCHLORIDE
RefChem:194147
(+/-)-Vesamicol HCl (AH-5183)
Cyclohexanol, 2-(4-phenylpiperidino)-, hydrochloride
2-(4-Phenylpiperidino)cyclohexanol hydrochloride
Computed Properties
Structural Parameters
Heavy atom count
20
Aromatic heavy atom count
6
Fraction Csp3
0.65
Rotatable bonds
2
H-bond acceptors
2
H-bond donors
1
Molar refractivity
85.5
TPSA
23.47
LogP / Solubility
WLOGP
3.59
MLOGP
3.17
XLogP3
3.59
Consensus LogP
3.45
Log S (ESOL)
-4.03
Class (ESOL)
Slightly soluble
Log S (Ali)
-4.58
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-4.8
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-1.97
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
2.5